Inventor
SAHARA YUIKO
JP22 patents
⚠️ This page may combine multiple inventors who share the name “SAHARA YUIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INOUYE SATOSHI
10 patentsUS8642281B2Feb 4, 2014
Coelenterazine analogues and coelenteramide analogues
INOUYE SATOSHI12 citations92
US8853374B2Oct 7, 2014
Process for production of recombinant proteins as a soluble form
INOUYE SATOSHI6 citations84
US8546568B2Oct 1, 2013
Coelenterazine analogs and manufacturing method thereof
INOUYE SATOSHI9 citations82
US8236526B2Aug 7, 2012
Calcium-binding photoprotein, gene encoding the same, and use thereof
INOUYE SATOSHI2 citations62
US8772452B2Jul 8, 2014
Calcium-binding photoprotein
INOUYE SATOSHI0 citations52
US8569003B2Oct 29, 2013
Fusion protein having luminescence activity
INOUYE SATOSHI0 citations52
US8563270B2Oct 22, 2013
Calcium-binding photoprotein, gene encoding the same, and use thereof
INOUYE SATOSHI0 citations52
US8481702B2Jul 9, 2013
Fusion protein having luminescence activity
INOUYE SATOSHI0 citations52
US8399616B2Mar 19, 2013
Fusion protein having luminescence activity
INOUYE SATOSHI0 citations52
US8394603B2Mar 12, 2013
Codon-optimized nucleic acid for coding apo-clytin-II and method for using the same
INOUYE SATOSHI0 citations52
JNC CORP
10 patentsUS9151739B2Oct 6, 2015
Coelenterazine analogs and manufacturing method thereof
JNC CORP14 citations91
US9075058B2Jul 7, 2015
Coelenterazine analogues and coelenteramide analogues
JNC CORP9 citations84
US9056840B2Jun 16, 2015
Coelenterazine analogues and coelenteramide analogues
JNC CORP6 citations84
US8883432B2Nov 11, 2014
Coelenterazine analogues and coelenteramide analogues
JNC CORP9 citations84
US8765921B2Jul 1, 2014
Coelenterazine analogs and manufacturing method thereof
JNC CORP9 citations82
US10156557B2Dec 18, 2018
Calcium-binding photoprotein
JNC CORP0 citations52
US9738692B2Aug 22, 2017
Process for production of recombinant proteins as a soluble form
JNC CORP0 citations52
US8476038B1Jul 2, 2013
Method for determining capability of a compound for inhibiting a receptor using codon-optimized nucleic acid
JNC CORP0 citations52
US8476436B1Jul 2, 2013
Method for enhancing luminescence intensity of clytin-II
JNC CORP0 citations52
US9645128B2May 9, 2017
Substituted imidazo[1,2-A]pyrazines for measuring a transcription activity
JNC CORP0 citations51